FTC Investigations of Provider Healthcare Transactions: Am I at Risk?

by BakerHostetler
Contact

A recent article published in the Antitrust Law Journal titled "A Survey of Evidence Leading to Second Requests at the FTC," by Darren S. Tucker, an attorney advisor to an FTC commissioner who reviewed nonpublic information on the decisions to investigate proposed transactions for the period August 2008 to August 2012, sheds light on the types of evidence used by the FTC staff to determine whether a transaction warrants a "second request" under the Hart-Scott-Rodino (HSR) Act. The issuance of a "second request" is a significant event because it prevents the parties to a proposed transaction from closing until after they have complied substantially with the request for additional information and have observed a second waiting period. As the article rightly notes, the "decision whether to issue" a "second request" is "a critical stage of the HSR process."

So, what evidence does the FTC staff look at to determine whether a transaction warrants a "second request"? Based on the article, a number of observations can be made about healthcare transactions involving the merger or other combination of competing hospitals, physician services groups, medical laboratories and pharmacies that led to a "second request" (hereafter "provider healthcare transactions").

First, according to the article, for those provider healthcare transactions receiving a "second request," (1) the size and relative number of the "market" participants played a role 100 percent of the time; (2) the unlikelihood that competitive entry would deter or offset the anticompetitive effects of the proposed transaction played a role 83 percent of the time; (3) customer concerns that the proposed transaction would lead to anticompetitive effects played a role 67 percent of the time; and (4) internal "hot" documents from the combining providers themselves predicting that the proposed transaction will result in anticompetitive effects, such as higher prices or a loss of competition, played a role 50 percent of the time.

Second, according to the article, for those provider healthcare transactions determined to warrant a "second request," the change in the number of significant competitors also played a role. (The article identifies a significant competitor as a firm that either offers the products or services demanded by most customers in an area or exceeds a share threshold, which was often 5 percent.) The table below reports the change in number of "significant competitors" for those provider healthcare transactions that received a "second request." 

No Change

2 -->1

3-->2

4-->3

5-->4

6-->5

7-->6

8-->7

3

5

1

1

1

Not surprisingly, 9 of the 11 provider healthcare transactions that received a "second request" resulted in 3 or fewer "significant competitors" post-transaction.

And finally, according to the article, provider healthcare transactions that received a "second request" resulted in a high concentration post-merger. Concentration is measured by calculating the Herfindahl-Hirschman Index (HHI), which simply is the sum of the squares of the shares of the competitors in the "market." According to the antitrust agencies' guidelines for horizontal mergers, mergers that result in an increase in the HHI of more than 100 points with a post-merger HHI of at least 1,500 "often warrant scrutiny," whereas mergers resulting in an increase in the HHI of more than 200 with a post-merger HHI above 2,500 "will be presumed to be likely to enhance market power." (A merger enhances market power "if it is likely to encourage one or more firms to raise price, reduce output, diminish innovation, or otherwise harm customers as a result of diminished competitive constraints or incentives.") As noted in the table below, all but three of the provider healthcare transactions that received a "second request" resulted in an increase in the HHI of more than 200 with a post-merger HHI above 2,500. In other words, the vast majority of provider healthcare transactions receiving a "second request" were "presumed to be likely to enhance market power," based on high concentration after the proposed transaction and a large increase in the HHI.

Post-merger HHI

Change
in HHI
0-99

Change
in HHI
100-199

Change
in HHI
200-599

Change
in HHI
600-999

Change
in HHI
1,000-1,499

Change
in HHI
1,500-2,499

Change
in HHI
2,500+

Total

0-1,499

 

 

1

 

 

 

 

1

1,500-2,499

 

 

1

1

 

 

 

2

2,500-3,999

 

 

1

3

1

1

 

6

4,000-5,999

 

 

 

1

1

3

1

6

6,000+

 

 

1

 

 

1

2

4

Total

0

0

4

5

2

5

3

19

So, what does all of this mean in terms of predicting whether the FTC will investigate your proposed healthcare transactions? Antitrust counsel (and an economic expert) should be involved in your proposed healthcare transaction as soon as possible. Also, keep in mind that although a "second request" can only be issued in connection with transactions that are large enough to require a pre-merger filing under the HSR Act, the same factors are likely to apply to potential investigations of transactions that are too small to require an HSR filing and already may have been completed. The FTC and the U.S. Department of Justice (DOJ) regularly investigate mergers of healthcare providers even though no HSR filing was required.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© BakerHostetler | Attorney Advertising

Written by:

BakerHostetler
Contact
more
less

BakerHostetler on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
Feedback? Tell us what you think of the new jdsupra.com!